Poland· PL-100536394
Kygevvi
A doxecitine and doxribtimine product, registered in Poland by UCB Pharma S.A.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Doxecitine and doxribtimine is registered in 9 of 19 countries.
Countries holding a registration under ATC A16AX29 (doxecitine and doxribtimine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Doxecitine and doxribtimine · ATC A16AX29
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Manufacturer
- UCB Pharma S.A.
- Country
- Poland (PL)
- ATC code
- A16AX29
- ATC class
- Doxecitine and doxribtimine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AX29
Doxecitine and doxribtimine, as other registers publish it.
- DenmarkKygevviUCB Pharma S.A.
- United StatesKYGEVVIUCB, Inc.
- FinlandKYGEVVIUCB Pharma SA
- IcelandKYGEVVIUCB Pharma S.A.*
- CzechiaKYGEVVIUCB Pharma SA, Brusel
- BelgiumKygevvi 2 g - 2 gUCB Pharma
- NetherlandsKYGEVVI 2 g/2 g poeder voor drankUCB Pharma S.A.
- IrelandKYGEVVI 2 g/2 g powder for oral solutionUCB Pharma S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/87ff6ac7-b0f5-49bb-b352-69b2ed503177 GET /v1/drugs/87ff6ac7-b0f5-49bb-b352-69b2ed503177?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu doustnego",
"source": "urpl",
"strength": null,
"packaging": "Rpz ¦ EU/1/25/2013/001 ¦ 166734\n30 sasz.",
"substance": null,
"common_name": null,
"pl_product_id": "100536394",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about doxecitine and doxribtimine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.